EUVIMEDEUVIMED entdecken
Crossref

Systematic AQbD-Driven Formulation of Clarithromycin SNEDDS for Enhanced Biopharmaceutical Performance

Vivek U. Powar, Rajanikant B. Ghotane, Prathmesh R. Demanna, Rushikesh V. Kadam, Shreeyash D. Kotmire

International Journal of Drug Delivery Technology · 10.06.2026 · 16 (53s)

DOI: 10.25258/ijddt.16.53s.42 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 10.06.2026. Verfasst von Vivek U. Powar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic efficacy of clarithromycin, a BCS Class II medication, is limited by its poor water solubility, acid instability, and variable oral bioavailability. Analytical Quality by Design (AQbD) was used to build a SelfNanoemulsifying Drug Delivery System (SNEDDS) in order to get around these restrictions. To choose an appropriate oil, surfactant, and co-surfactant, solubility tests were carried out. Based on maximal solubility and emulsification efficiency, Tween 80 and Propylene Glycol were chosen as surfactants and co-surfactants, respectively, while Capryol 90 was chosen as the oil phase. Utilizing a 3² complete factorial design, formulation variables were optimized. Globule size, PDI, and drug release were chosen as dependent factors, whereas Capryol 90 concentration (X1) and Smix concentration (X2) were chosen as independent variables. With a globule size of 181.09 nm, a PDI of 0.269, and a drug release of 94.45%, the modified formulation demonstrated effective nanoemulsion production and improved dissolving behavior. When compared to the pure drug, the produced SNEDDS showed enhanced dissolving profile, rapid emulsification, high transparency, and strong thermodynamic stability. Clarithromycin SNEDDS formulation development and optimization for improved oral administration were successfully made possible by the AQbD technique.

Zitieren

APA

Powar, V. U., Ghotane, R. B., Demanna, P. R., Kadam, R. V., & Kotmire, S. D. (2026). Systematic AQbD-Driven Formulation of Clarithromycin SNEDDS for Enhanced Biopharmaceutical Performance. International Journal of Drug Delivery Technology, 16(53s). https://doi.org/10.25258/ijddt.16.53s.42

Vancouver

Powar VU, Ghotane RB, Demanna PR, Kadam RV, Kotmire SD. Systematic AQbD-Driven Formulation of Clarithromycin SNEDDS for Enhanced Biopharmaceutical Performance. International Journal of Drug Delivery Technology. 2026;16(53s). doi:10.25258/ijddt.16.53s.42

BibTeX
@article{Powar2026,
  author = {Powar, Vivek U. and Ghotane, Rajanikant B. and Demanna, Prathmesh R. and Kadam, Rushikesh V. and Kotmire, Shreeyash D.},
  title = {Systematic AQbD-Driven Formulation of Clarithromycin SNEDDS for Enhanced Biopharmaceutical Performance},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {53s},
  doi = {10.25258/ijddt.16.53s.42}
}
Kostenlos starten →